On the stock market since 2022, it operates in the world of money and finance. It has 1 employee. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Average growth of 64% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades 24% below its peak. The market has trimmed its expectations for the company.
Over the last 3 years, sales grew about 184% a year on average.
Sales run at $478K a year. A small number, but proof the product has real buyers.
A loss of $458K against $478K in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, RHNO sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: RHNO is a high-risk stock — not yet profitable, and its future rides on its product catching on.